TARDBP and proteostasis deficiencies: Furthermore, neuropathological studies clearly suggest that other proteinopathies, such as TDP-43 and alphasynuclein, likely contribute to cognitive decline in this age range (47, 48), but are currently lacking quantitative biomarkers that are easily obtained in vivo.